Yishai Levy
Research Subjects
Yishai Levy has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
A. Kerner
Departments of Cardiology
1 shared publicationA. Z. Reznick
Technion–Israel Institute of Technology
1 shared publicationAbraham Z. Reznick
Rambam Health Care Campus and Technion Faculty of Medicine, Haifa, Israel
1 shared publicationAmi Ben-Amotz
1 shared publicationB. Narotzki
Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
1 shared publicationB. Smolin
Department of Internal Medicince D, Technion Faculty of Medicine, Rambam Health Care Campus, Haifa, Israel
1 shared publication
Latest Publications
- 1 October 2021
- Vol. 23 (10) , 665-669
A Friend and a Foe: 50 Years of the Apolipoprotein E Research Trail
An arginine-rich apolipoprotein was discovered 50 years ago and became known as apolipoprotein E (ApoE) 10 years later. ApoE is associated with triglyceride-rich lipoproteins and mediates the clearance of these lipoproteins from the plasma. The ApoE-deficient hypercholesterolemic mice are an excellent platform for experimental atherosclerosis because they are similar to human pathology with regard to an atherogenic diet. ApoE is mainly produced in the liver and central nervous system cells. Three alleles determine six ApoE phenotypes with different metabolic effects and plasma cholesterol levels. Type III dysbetalipoproteinemia is associated with wide-spread atherogenesis with a defective ApoE2 resulting in delayed clearance of triglyceride-rich lipoproteins. ApoE4 substantially increases the risk including age of onset, progression, and prognosis of Alzheimer's disease. Therefore, much effort has been directed to the elucidation of the pathogenic role of ApoE related to amyloid beta (A beta) acquisition in the brain. The ApoE trail passing from an enigmatic protein to a major player in cardiovascular and neurodegenerative disorders is reviewed.
- 1 October 2021
- Vol. 23 (10) , 665-669
A Friend and a Foe: 50 Years of the Apolipoprotein E Research Trail
An arginine-rich apolipoprotein was discovered 50 years ago and became known as apolipoprotein E (ApoE) 10 years later. ApoE is associated with triglyceride-rich lipoproteins and mediates the clearance of these lipoproteins from the plasma. The ApoE-deficient hypercholesterolemic mice are an excellent platform for experimental atherosclerosis because they are similar to human pathology with regard to an atherogenic diet. ApoE is mainly produced in the liver and central nervous system cells. Three alleles determine six ApoE phenotypes with different metabolic effects and plasma cholesterol levels. Type III dysbetalipoproteinemia is associated with wide-spread atherogenesis with a defective ApoE2 resulting in delayed clearance of triglyceride-rich lipoproteins. ApoE4 substantially increases the risk including age of onset, progression, and prognosis of Alzheimer's disease. Therefore, much effort has been directed to the elucidation of the pathogenic role of ApoE related to amyloid beta (A beta) acquisition in the brain. The ApoE trail passing from an enigmatic protein to a major player in cardiovascular and neurodegenerative disorders is reviewed.
- 1 February 2017
- Published by Elsevier in Clinical Nutrition
- Vol. 36 (1) , 315
Green tea, weight loss and physical activity
- 1 February 2017
- Published by Elsevier in Clinical Nutrition
- Vol. 36 (1) , 315
Green tea, weight loss and physical activity
- 1 September 2015
- Published by Elsevier in Archives of Oral Biology
- Vol. 60 (9) , 1461-1462
Oxidative stress, antioxidants and periodontal disease
- 1 September 2015
- Published by Elsevier in Archives of Oral Biology
- Vol. 60 (9) , 1461-1462
Oxidative stress, antioxidants and periodontal disease
- 14 October 2014
- Published by Hindawi Limited in International Journal Of Clinical Practice
- Vol. 69 (4) , 501-508
Predicting mortality of elderly patients acutely admitted to the Department of Internal Medicine
This study addresses the common practice of providing aggressive treatments of limited clinical benefit and cost-effectiveness to seriously ill and frail elderly. We have created a statistical model of 6-month mortality risk prediction following acute hospitalisation admission, and identified a subset of patients with poorest prognosis that requires comfort-focused care. We have studied electronic medical records of 26,937 patients age 65 years or older, hospitalised in the internal medicine departments of one tertiary-care teaching medical center in Northern Israel from January 1, 2008 through December 31, 2011 and mortality data from the Israeli Internal Ministry Registry. Norton score records were employed for the performance status evaluation. Multivariate logistic regression analysis was used to predict the risk of 6-month mortality. Variables associated with an increased risk of 6-month mortality included: metastatic cancer, age above 85 years, decreased values of blood albumin and haemoglobin, increased blood urea nitrogen and decreased physical/mental status and activity. The receiver operating characteristic area for the predicted probability of death was 0.845 and 0.847 in external validation cohort. Using predictive values of the logistic regression analysis, the study cohort was stratified into six groups with various predictive mortality risks. The majority of deaths that have occurred within 6 months following the acute hospitalisation could be predicted on patient admission based on a few simple and easily obtained parameters. Earlier recognition of patients nearing the end of their lives may lead to better care and more efficient use of available resource.
- 14 October 2014
- Published by Hindawi Limited in International Journal Of Clinical Practice
- Vol. 69 (4) , 501-508
Predicting mortality of elderly patients acutely admitted to the Department of Internal Medicine
This study addresses the common practice of providing aggressive treatments of limited clinical benefit and cost-effectiveness to seriously ill and frail elderly. We have created a statistical model of 6-month mortality risk prediction following acute hospitalisation admission, and identified a subset of patients with poorest prognosis that requires comfort-focused care. We have studied electronic medical records of 26,937 patients age 65 years or older, hospitalised in the internal medicine departments of one tertiary-care teaching medical center in Northern Israel from January 1, 2008 through December 31, 2011 and mortality data from the Israeli Internal Ministry Registry. Norton score records were employed for the performance status evaluation. Multivariate logistic regression analysis was used to predict the risk of 6-month mortality. Variables associated with an increased risk of 6-month mortality included: metastatic cancer, age above 85 years, decreased values of blood albumin and haemoglobin, increased blood urea nitrogen and decreased physical/mental status and activity. The receiver operating characteristic area for the predicted probability of death was 0.845 and 0.847 in external validation cohort. Using predictive values of the logistic regression analysis, the study cohort was stratified into six groups with various predictive mortality risks. The majority of deaths that have occurred within 6 months following the acute hospitalisation could be predicted on patient admission based on a few simple and easily obtained parameters. Earlier recognition of patients nearing the end of their lives may lead to better care and more efficient use of available resource.
- 10 October 2014
- Published by Springer Nature
- Vol. 832, 25-33
Green Tea Drinking Improves Erythrocytes and Saliva Oxidative Status in the Elderly
We have previously shown that green tea (GT) drinking combined with vitamin E supplementation reduced plasma protein carbonyls and increased erythrocytes catalase activity in exercising healthy elderly. In the present study we set out to investigate the antioxidative effects of GT drinking in an aging population. We performed an interventional, crossover, controlled prospective trial with 35 healthy elderly subjects (mean age 67.3 ± 4.8 years), supplemented with four daily placebo maltodextrin “tea-bags” for 12 weeks, followed by four 1.5 g daily GT bags for another 12 weeks. Data were obtained at baseline, at the end of the placebo period, and at the end of the GT intervention period. We found that GT did not alter erythrocyte catalase activity. However, it provided protection against 2,2′-azobis (2-amidinopropane) dihydrochloride (AAPH)-induced oxidative hemolysis which declined by 10.2 % (p < 0.001). No changes were observed in saliva oral peroxidase enzymes. Nonetheless, saliva total antioxidant capacity increased by 42.0 % (p < 0.01). Plasma oxidative products, such as protein carbonyls, lipid peroxides and thiobarbituric acid reactive substances (TBARS) were stable throughout the intervention period. We conclude that four daily cups of GT are well tolerated in elderly free living subjects. Our results demonstrate that both erythrocyte resistances to oxidation and saliva antioxidant capacity are improved by GT drinking. The clinical implications of these oxidation modifications require further research.
- 10 October 2014
- Published by Springer Nature
- Vol. 832, 25-33
Green Tea Drinking Improves Erythrocytes and Saliva Oxidative Status in the Elderly
We have previously shown that green tea (GT) drinking combined with vitamin E supplementation reduced plasma protein carbonyls and increased erythrocytes catalase activity in exercising healthy elderly. In the present study we set out to investigate the antioxidative effects of GT drinking in an aging population. We performed an interventional, crossover, controlled prospective trial with 35 healthy elderly subjects (mean age 67.3 ± 4.8 years), supplemented with four daily placebo maltodextrin “tea-bags” for 12 weeks, followed by four 1.5 g daily GT bags for another 12 weeks. Data were obtained at baseline, at the end of the placebo period, and at the end of the GT intervention period. We found that GT did not alter erythrocyte catalase activity. However, it provided protection against 2,2′-azobis (2-amidinopropane) dihydrochloride (AAPH)-induced oxidative hemolysis which declined by 10.2 % (p < 0.001). No changes were observed in saliva oral peroxidase enzymes. Nonetheless, saliva total antioxidant capacity increased by 42.0 % (p < 0.01). Plasma oxidative products, such as protein carbonyls, lipid peroxides and thiobarbituric acid reactive substances (TBARS) were stable throughout the intervention period. We conclude that four daily cups of GT are well tolerated in elderly free living subjects. Our results demonstrate that both erythrocyte resistances to oxidation and saliva antioxidant capacity are improved by GT drinking. The clinical implications of these oxidation modifications require further research.
- 28 November 2003
- Published by Wiley in Diabetic Medicine
- Vol. 21 (1) , 39-44
Association between fasting glucose and C‐reactive protein in middle‐aged subjects
Aims C‐reactive protein (CRP), a marker of subclinical inflammation, predicts the occurrence of coronary heart disease in healthy subjects. Hyperglycaemia is known to stimulate the release of inflammatory cytokines from various cell types and can lead to the induction and secretion of acute‐phase reactants by adipocytes. The aim of the present study was to determine the relation between glycaemic status and CRP in healthy subjects.Methods We studied the relation of high‐sensitivity CRP to fasting glucose and other components of the metabolic syndrome in a population‐based cross‐sectional study (n = 1000; age 50 ± 9 years).Results Plasma CRP levels increased continuously from the lowest quartile of normal fasting glucose level to impaired fasting glucose and to diabetes (ln CRP 0.47 ± 0.09, 0.95 ± 0.12, and 1.11 ± 0.13, respectively; Ptrend < 0.0001). Increasing CRP with higher fasting glucose levels was apparent even among subjects with fasting glucose in the normal range (Ptrend = 0.039), and subjects with fasting glucose level in the upper quartile of normal fasting glucose had higher CRP levels compared with subjects in the lower quartile (P = 0.035). There was a positive crude correlation between CRP and smoking, post‐menopausal hormone use, body mass index, fasting glucose, triglycerides, hypertension, and uric acid (r = 0.11–0.36, P = 0.002–0.0001). A negative correlation was found between CRP and HDL‐cholesterol (r = 0.12, P < 0.0001) and physical activity (r = 0.11, P = 0.002). After adjustment for potential confounders in a stepwise multivariate linear regression model, fasting glucose remained significantly and independently related to CRP levels (correlation coefficient 0.06; 95% confidence interval 0.014–0.11, P = 0.011).Conclusions Fasting glucose is significantly and positively associated with plasma CRP in middle‐aged subjects. CRP levels increase continuously across the spectrum of fasting glucose, beginning in the lowest quartile of normal fasting glucose. This finding suggests that a proinflammatory effect may contribute to the adverse cardiovascular outcome associated with diabetes, impaired fasting glucose, and increasing glucose levels within the normal range.
- 28 November 2003
- Published by Wiley in Diabetic Medicine
- Vol. 21 (1) , 39-44
Association between fasting glucose and C‐reactive protein in middle‐aged subjects
Aims C‐reactive protein (CRP), a marker of subclinical inflammation, predicts the occurrence of coronary heart disease in healthy subjects. Hyperglycaemia is known to stimulate the release of inflammatory cytokines from various cell types and can lead to the induction and secretion of acute‐phase reactants by adipocytes. The aim of the present study was to determine the relation between glycaemic status and CRP in healthy subjects.Methods We studied the relation of high‐sensitivity CRP to fasting glucose and other components of the metabolic syndrome in a population‐based cross‐sectional study (n = 1000; age 50 ± 9 years).Results Plasma CRP levels increased continuously from the lowest quartile of normal fasting glucose level to impaired fasting glucose and to diabetes (ln CRP 0.47 ± 0.09, 0.95 ± 0.12, and 1.11 ± 0.13, respectively; Ptrend < 0.0001). Increasing CRP with higher fasting glucose levels was apparent even among subjects with fasting glucose in the normal range (Ptrend = 0.039), and subjects with fasting glucose level in the upper quartile of normal fasting glucose had higher CRP levels compared with subjects in the lower quartile (P = 0.035). There was a positive crude correlation between CRP and smoking, post‐menopausal hormone use, body mass index, fasting glucose, triglycerides, hypertension, and uric acid (r = 0.11–0.36, P = 0.002–0.0001). A negative correlation was found between CRP and HDL‐cholesterol (r = 0.12, P < 0.0001) and physical activity (r = 0.11, P = 0.002). After adjustment for potential confounders in a stepwise multivariate linear regression model, fasting glucose remained significantly and independently related to CRP levels (correlation coefficient 0.06; 95% confidence interval 0.014–0.11, P = 0.011).Conclusions Fasting glucose is significantly and positively associated with plasma CRP in middle‐aged subjects. CRP levels increase continuously across the spectrum of fasting glucose, beginning in the lowest quartile of normal fasting glucose. This finding suggests that a proinflammatory effect may contribute to the adverse cardiovascular outcome associated with diabetes, impaired fasting glucose, and increasing glucose levels within the normal range.
- 1 September 2002
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 13 (6) , 396-397
An unusual case of gastric outlet obstruction.
- 1 September 2002
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 13 (6) , 396-397
An unusual case of gastric outlet obstruction.
- 1 September 2001
- Vol. 3 (9) , 704
Myalgia, fever, abnormal muscle enzymes and blue urine in a farmworker from Thailand.
- 1 September 2001
- Vol. 3 (9) , 704
Myalgia, fever, abnormal muscle enzymes and blue urine in a farmworker from Thailand.
- 1 April 2000
- Published by S. Karger AG in Annals of Nutrition and Metabolism
- Vol. 44 (2) , 54-60
Dietary Supplementation of a Natural Isomer Mixture of Beta-Carotene Inhibits Oxidation of LDL Derived from Patients with Diabetes mellitus
Background: Accelerated atherosclerosis is common in patients with diabetes mellitus which may be linked to increased lipid peroxidation. Therefore, we compared the oxidation of LDL derived from patients with diabetes to normoglycemic controls and followed-up the effect of dietary β-carotene supplementation on LDL oxidation. Methods: Twenty patients with long-standing non-insulin-dependent diabetes mellitus were studied in comparison with age- and sex-matched control subjects. Dunaliella bardawil-derived β-carotene was supplemented to the patients for 3 weeks, 60 mg daily dose. LDL oxidation was analyzed by measuring malondialdehyde (MDA), lipid peroxides (PD), and conjugated dienes (CD) generation in response to CuSO4-induced oxidation. LDL lipid composition and the LDL associated vitamins A, E and carotenoids were also measured. Results: LDL susceptibility to oxidation by CuSO4 was increased in the patients by 40% with a 35% shorter lag time required for the initiation of LDL oxidation, i.e. 56 ± 6 min in patients vs. 85 ± 9 min in controls (p Conclusions: Increased susceptibility to oxidation of LDL derived from patients with diabetes mellitus is associated with abnormal LDL lipid composition and antioxidant content. Natural β-carotene dietary supplementation normalizes the enhanced LDL oxidation and consequently may be of importance in delaying accelerated development of atherosclerosis in these patients.
- 1 April 2000
- Published by S. Karger AG in Annals of Nutrition and Metabolism
- Vol. 44 (2) , 54-60
Dietary Supplementation of a Natural Isomer Mixture of Beta-Carotene Inhibits Oxidation of LDL Derived from Patients with Diabetes mellitus
Background: Accelerated atherosclerosis is common in patients with diabetes mellitus which may be linked to increased lipid peroxidation. Therefore, we compared the oxidation of LDL derived from patients with diabetes to normoglycemic controls and followed-up the effect of dietary β-carotene supplementation on LDL oxidation. Methods: Twenty patients with long-standing non-insulin-dependent diabetes mellitus were studied in comparison with age- and sex-matched control subjects. Dunaliella bardawil-derived β-carotene was supplemented to the patients for 3 weeks, 60 mg daily dose. LDL oxidation was analyzed by measuring malondialdehyde (MDA), lipid peroxides (PD), and conjugated dienes (CD) generation in response to CuSO4-induced oxidation. LDL lipid composition and the LDL associated vitamins A, E and carotenoids were also measured. Results: LDL susceptibility to oxidation by CuSO4 was increased in the patients by 40% with a 35% shorter lag time required for the initiation of LDL oxidation, i.e. 56 ± 6 min in patients vs. 85 ± 9 min in controls (p Conclusions: Increased susceptibility to oxidation of LDL derived from patients with diabetes mellitus is associated with abnormal LDL lipid composition and antioxidant content. Natural β-carotene dietary supplementation normalizes the enhanced LDL oxidation and consequently may be of importance in delaying accelerated development of atherosclerosis in these patients.